Rights and permissions
About this article
Cite this article
Lumiracoxib needs competitive label to succeed on market, says ML. Pharmacoecon. Outcomes News 403, 12 (2003). https://doi.org/10.1007/BF03275984
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275984